￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Detailed introduction to the instruction manual of revumenib

2026-01-15 06:18:33

On October 24,2025,Syndax Pharmaceuticals announced that the U.S.Food and Drug Administration(FDA)has approved Revuforj(revumenib)for the treatment of adult and pediatric patients aged 1 year and older with relapsed or refractory(R/R)acute myeloid leukemia(AML)carrying nucleolar phosphoprotein 1(NPM1)mutations and for whom there are no suitable alternative treatment options.Revuforj was previously approved in 2024 for the treatment of adult and pediatric patients aged 1 year and older with R/R acute leukemia associated with a lysine methyltransferase 2A gene(KMT2A)translocation.

Check Details
Ryeqo (Relugolix compound tablets) - long-term treatment for uterine fibroids

2025-10-19 11:44:20

Check Details
How effective is Ryeqo (Relugolix compound tablets)?

2025-10-19 11:44:20

Check Details
U.S. FDA approves Ryeqo to treat menorrhagia related to uterine fibroids in premenopausal women!

2025-10-19 11:44:20

Check Details
How much does Ryeqo cost? Where can I buy it in Liaoning?

2025-10-19 11:44:20

Check Details
Ryeqo - a good medicine that can effectively improve menorrhagia and pain caused by uterine fibroids

2025-10-19 11:44:20

Check Details
How much does Ryeqo cost? Is it available in Shandong now?

2025-10-19 11:44:20

Check Details
Comprehensive summary-the advantages, disadvantages and indications of different preparations of estradiol

2025-10-19 11:44:20

Check Details
What is the therapeutic effect of myfembree

2025-10-19 11:44:20

Check Details
What are the serious side effects of myfembree and how to deal with them?

2025-10-19 11:44:20

Check Details
How effective is Ryeqo in treating uterine fibroids?

2025-10-19 11:44:20

Check Details
How to use Ryeqo correctly?

2025-10-19 11:44:20

Check Details
Category
相关知识